Parkwood LLC Gilead Sciences, Inc. Transaction History

Parkwood LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $996,280 - $1.1 Million	-13,977 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $11,678 - $13,622	180 Added 1.3%	13,977 $990,000
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $82,236 - $100,255	-1,129 Reduced 7.56%	13,797 $1.04 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $109,784 - $128,871	-1,543 Reduced 9.37%	14,926 $1.07 Million
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $1.19 Million - $1.41 Million	16,469	16,469 $1.33 Million

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.